Mizuho analyst Steven Valiquette raised the firm’s price target on Henry Schein (HSIC) to $78 from $75 and keeps a Neutral rating on the shares. The company reported preliminary Q4 results that ...

It has been about a month since the last earnings report for Henry Schein (HSIC). Shares have lost about 3.9% in that time frame, outperforming the S&P 500. Will the recent negative trend continue ...

MELVILLE, N.Y.--(BUSINESS WIRE)-- Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that ...